HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne Barton Selected Research

Anne Barton Research Topics

Disease

100Rheumatoid Arthritis
11/2022 - 05/2002
23Arthritis (Polyarthritis)
01/2022 - 01/2004
17Necrosis
10/2019 - 10/2007
16Psoriasis (Pustulosis Palmaris et Plantaris)
06/2021 - 01/2004
10Psoriatic Arthritis
06/2021 - 01/2004
8Inflammation (Inflammations)
11/2022 - 07/2012
7Autoimmune Diseases (Autoimmune Disease)
01/2018 - 03/2004
5Joint Diseases (Joint Disease)
01/2016 - 06/2007
4Rheumatic Diseases (Rheumatism)
01/2020 - 05/2015
4Genetic Predisposition to Disease (Genetic Predisposition)
01/2019 - 03/2011
3Crohn Disease (Crohn's Disease)
02/2014 - 03/2005
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2009 - 06/2005
2Synovitis
10/2020 - 03/2019
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021
1Systemic Scleroderma (Systemic Sclerosis)
01/2021
1Fatigue
10/2020
1Infections
01/2019
1Obesity
01/2018
1Pneumonia (Pneumonitis)
12/2017
1Spondylarthropathies
10/2017
1Ankylosing Spondylitis
10/2017
1Vasculitis (Vasculitides)
01/2017
1Acquired Immunodeficiency Syndrome (AIDS)
01/2016
1Disease Susceptibility (Diathesis)
04/2015
1Genetic Risk Score
01/2015
1Neoplasms (Cancer)
02/2014
1Breast Neoplasms (Breast Cancer)
07/2013
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2011

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
11/2020 - 08/2013
16Methotrexate (Mexate)FDA LinkGeneric
10/2021 - 02/2014
15Biological ProductsIBA
10/2020 - 01/2013
13Tumor Necrosis Factor InhibitorsIBA
10/2021 - 01/2011
13AntibodiesIBA
01/2020 - 05/2010
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 10/2007
10HLA-DRB1 Chains (HLA DRB1)IBA
01/2022 - 12/2004
9Biomarkers (Surrogate Marker)IBA
10/2021 - 12/2015
9AutoantibodiesIBA
01/2021 - 06/2005
8Anti-Citrullinated Protein AntibodiesIBA
01/2022 - 02/2008
7Adalimumab (Humira)FDA Link
11/2022 - 06/2014
7Etanercept (Enbrel)FDA Link
01/2019 - 03/2013
7Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2004
7Rheumatoid FactorIBA
01/2016 - 01/2004
5C-Reactive ProteinIBA
10/2020 - 10/2012
5Antirheumatic Agents (DMARD)IBA
10/2020 - 11/2008
5EpitopesIBA
01/2018 - 06/2007
5ametantrone (HAQ)IBA
11/2016 - 01/2010
5cyclic citrullinated peptideIBA
01/2016 - 02/2008
4Amino AcidsFDA Link
01/2022 - 01/2015
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2011
4HLA-C Antigens (HLA-C)IBA
08/2019 - 11/2010
4Peptides (Polypeptides)IBA
12/2012 - 05/2012
3Genetic Markers (Genetic Marker)IBA
11/2016 - 12/2012
3Interleukin-13IBA
08/2012 - 09/2010
2RNA (Ribonucleic Acid)IBA
01/2018 - 12/2015
2HLA-B Antigens (HLA-B)IBA
10/2017 - 01/2015
2Valine (L-Valine)FDA Link
11/2016 - 04/2015
2Immunoglobulin G (IgG)IBA
01/2016 - 03/2015
2Infliximab (Remicade)FDA Link
03/2015 - 06/2014
2AntigensIBA
01/2015 - 06/2007
2Vitamin DFDA LinkGeneric
07/2014 - 05/2014
2TNF Receptor-Associated Factor 1IBA
02/2013 - 01/2010
2Toll-Like Receptors (Toll-Like Receptor)IBA
12/2010 - 07/2010
2Type II Tumor Necrosis Factor ReceptorsIBA
05/2010 - 08/2005
2CytokinesIBA
10/2007 - 03/2005
1Pharmacological BiomarkersIBA
01/2020
1Interleukin-10 (Interleukin 10)IBA
10/2019
1Interleukin-17 (Interleukin 17)IBA
10/2019
1amsonic acid (DAS)IBA
03/2019
1ChromatinIBA
01/2019
1Opioid Analgesics (Opioids)IBA
01/2019
1SteroidsIBA
01/2019
1tocilizumab (atlizumab)FDA Link
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2018
1HLA-A31 antigenIBA
12/2017
1Interleukin-4 (Interleukin 4)IBA
11/2017
1Serine (L-Serine)FDA Link
10/2017
1AsparagineIBA
10/2017
1Certolizumab PegolFDA Link
01/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2016
1interleukin 20 (IL-20)IBA
11/2016
1Monoclonal AntibodiesIBA
11/2016
1Interleukin-6 (Interleukin 6)IBA
11/2016
1CXC ChemokinesIBA
11/2015
1LigandsIBA
11/2015
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2015
1Anti-Idiotypic AntibodiesIBA
02/2015
1HLA-DPB1 antigen (HLA DPB1)IBA
01/2015
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
04/2014
1IGF-I-IGFBP-3 complexFDA Link
10/2012
1HLA-B27 Antigen (HLA B27 Antigen)IBA
08/2012
1Rituximab (Mabthera)FDA Link
07/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2012
1Phosphotransferases (Kinase)IBA
01/2011
1NF-kappa B (NF-kB)IBA
07/2010
1EnzymesIBA
05/2010
1Protein-Arginine Deiminase Type 4IBA
04/2010

Therapy/Procedure

28Therapeutics
11/2022 - 04/2009
6Biological Therapy
10/2020 - 03/2013
3Precision Medicine
01/2020 - 07/2015
1Immunomodulation
01/2018